Kembali
KLBF - Kalbe Farma

KLBF - Allocating capex IDR1 tn

13 Februari 2023

Kalbe Farma (KLBF) continuously expanding market share worldwide. To support the plan, the company has allocated capex amounting IDR1 tn. Despite making only small portion to total revenue, it is expected that the joint venture company could smoothen raw material supply chain and will strengthen KLBF positioned ing forward. (Source : Kontan). Comment: We like KLBF continuing effort to penetrate and developglobal market. This could overall help earnings growth to remain arrive at double digit level. Post commercially operated and raw material supply chain will get more efficient, margin should expanded and brought RoE to record higher figure year-on-year which provide more ample room for better dividend yield.

Related Research

Healthcare
KLBF - 9M25 results came in-line on solid 3Q25 sales growth
Andre Suntono 31 Oktober 2025 Lihat Detail
Consumer
KLBF - Expects a Brighter 24F, after a weak 23f
Andre Suntono 20 Maret 2024 Lihat Detail
Healthcare
KLBF - Sustaining growth further, after solid 1H25 results
Andre Suntono 28 Agustus 2025 Lihat Detail